483
Lawrence Ginsberg, M.D.FDA 483 - Lawrence Ginsberg, M.D. - July 29, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Lawrence Ginsberg, M.D. in Houston, TX, a clinical investigator, revealed that investigations were not conducted in accordance with the signed statement of investigator and investigational plan. The firm failed to ensure contemporaneous documentation of subject eligibility decisions and proper attribution of screening assessments. These findings indicate significant deficiencies in record-keeping and adherence to study protocols.
- Office
- Dallas District Office
- Person
Open in Dashboard
ID · f212a243-ab8b-4617-b026-fc2a14195fe4